Saracatinib (AZD0530) is a potent, highly selective Src/Abl kinase inhibitor. It affects PI3K/AKT, Src/ERK, and JAK-STAT3 signaling pathways by blocking kinase activity and downstream phosphorylation, to inhibit tumor cell proliferation, migration, invasion, and fibrotic responses.
Saracatinib (AZD0530) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Saracatinib (AZD0530) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- Saracatinib (AZD0530) Mechanism of Action: Fyn Inhibition in Neuronal Cell Research
- Saracatinib (AZD0530) Clinical Trials
- Saracatinib (AZD0530) Working Concentration | Cell Culture | Treatment
- Saracatinib (AZD0530) Solubility in DMSO
- Saracatinib (AZD0530) Stock Solution
- Saracatinib (AZD0530) Storage
- Saracatinib (AZD0530) Stability
- Saracatinib (AZD0530) Combination Database
- Saracatinib (AZD0530) Molecular Weight
- Saracatinib (AZD0530) SMILES
- Saracatinib (AZD0530) CAS Number
- Saracatinib (AZD0530) Chemical Structure (2D and 3D)
- Saracatinib (AZD0530) Cayman (11497)? Try a better option.
- Saracatinib (AZD0530) Tocris (7189)? Try a better option.
- Saracatinib (AZD0530) Sigma (SML3195)? Try a better option.
- Saracatinib (AZD0530) MedChemExpress (HY-10234)? Try a better option.
- Saracatinib (AZD0530) SDS｜MSDS